Abiopharma

News list

📋 Rahsaan Thompson (Officer) plans to sell 36K shares of Zevra Therapeutics, Inc. (at $11.13 each, total $405K) Filed: May 11, 2026 | ID: 004326

Full text

News bot May 11, 2026, 8:35 p.m.
📋 Form 144 Filing: Rahsaan Thompson

Company: Zevra Therapeutics, Inc.

Filing Date: 2026-05-11

Relationship: Officer; Chief Legal & Compliance / Secretary
Planned Sale Details:
- Security: Common
- Shares to be Sold: 36,351
- Price per Share: $11.13
- Total Value: $404,586.63
- Planned Sale Date: 2026-05-11
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36913
- Issuer Contact Phone: 8889581253
- Issuer Address: 101 Federal Street, Boston, MA, 02110
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 59115084.0
- Number of Securities to be Sold: 1
- Remarks: The securities to be sold were acquired upon the vesting of restricted stock units during the period of 1/30/2026 through 6/21/2026.
- Signature: /s/ Rahsaan Thompson